EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Host–Pathogen Interactions in Tuberculosis: Emerging Strategies for Therapeutic Intervention

Mohammad J Nasiri iD, Vishwanath Venketaraman iD

International Journal of Molecular Sciences · 14.02.2025 · 26 (4) · 1621

DOI: 10.3390/ijms26041621 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.02.2025. Verfasst von Mohammad J Nasiri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 19839-69411, Iran. Hauptthemen laut MEDLINE: Tuberculosis, Mycobacterium tuberculosis, Host-Pathogen Interactions. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH-NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB) remains one of the most challenging infectious diseases, with Mycobacterium tuberculosis (Mtb) employing sophisticated mechanisms to evade host immunity and establish persistent infections. This review explores recent advances in understanding Mtb’s immune evasion strategies; granuloma dynamics; and emerging immunotherapeutic approaches. Key findings highlight the manipulation of host autophagy; metabolic reprogramming; and cytokine pathways by Mtb to sustain its survival within host cells. Insights into granuloma formation reveal the critical role of bacterial lipids; immune modulation; and hypoxia-driven dormancy in maintaining chronic infection. Innovative therapeutic strategies, including host-directed therapies; epigenetic interventions; and immunomodulators, hold promise for improving TB management and combating drug-resistant strains. Despite these advancements, significant challenges remain, including the development of effective vaccines; addressing latent TB; and ensuring equitable access to novel treatments. The integration of advanced technologies such as artificial intelligence and multi-omics approaches, alongside global collaboration, is essential to overcome these hurdles. This review underscores the importance of a multidisciplinary approach to tackling TB, with the ultimate goal of eradicating this global health threat.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TuberculosisMycobacterium tuberculosisHost-Pathogen InteractionsHumansAnimalsAntitubercular AgentsAutophagyImmunotherapyImmune Evasion

Stichwörter der Autor:innen

Mycobacterium tuberculosishost immune mechanismsvirulence factors

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 19839-69411, Iran.
  • College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USA.

ORCID-Profile: Mohammad J Nasiri, Vishwanath Venketaraman

Förderung

  • NHLBI NIH HHS
  • NIH-NHLBI

Zitieren

APA

Nasiri, M. J., & Venketaraman, V. (2025). Advances in Host–Pathogen Interactions in Tuberculosis: Emerging Strategies for Therapeutic Intervention. International Journal of Molecular Sciences, 26(4), 1621. https://doi.org/10.3390/ijms26041621

Vancouver

Nasiri MJ, Venketaraman V. Advances in Host–Pathogen Interactions in Tuberculosis: Emerging Strategies for Therapeutic Intervention. International Journal of Molecular Sciences. 2025;26(4):1621. doi:10.3390/ijms26041621

BibTeX
@article{Nasiri2025,
  author = {Nasiri, Mohammad J and Venketaraman, Vishwanath},
  title = {Advances in Host–Pathogen Interactions in Tuberculosis: Emerging Strategies for Therapeutic Intervention},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {4},
  pages = {1621},
  doi = {10.3390/ijms26041621}
}
Kostenlos starten →